Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine

Unifying pathologists, workflows, and AI to amplify expertise

Psychedelic Medicines Approach a Historic FDA Approval Milestone with Safety Under Scrutiny

The FDA's historic psychedelic hearing highlighted a critical question: how can psychedelic medicines become accessible without compromising patient safety? As developers move closer to potential approvals, regulators must balance clinical evidence, professional oversight, workforce training, geographic access and long-term safety.

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

FibroFind appoints leading transplant physician Professor Andrew Fisher as Chief Medical Officer

Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform

Qinecsa has been selected as technology partner for AfriVigilance, the African Medicines Agency’s new continent-wide medicines safety surveillance platform, with implementation already underway.

FDA Approves AstraZeneca’s Etcamah, Bringing ctDNA-Guided Treatment to Breast Cancer

AstraZeneca’s Etcamah has received FDA accelerated approval for ctDNA-guided treatment in HR-positive, HER2-negative breast cancer with ESR1 mutations. The decision could establish an earlier treatment-switch strategy based on molecular changes before cancer becomes visible on scans.

Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models

The study evaluated NetraAI technology across clinical datasets in schizophrenia, major depressive disorder and pancreatic cancer, benchmarking the technology against eight industry-standard predictive models. The findings show NetraAI's biological and clinical signatures successfully boosted the accuracy of all eight evaluated algorithms across every single dataset tested.

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Targeting a signal released by dormant cancer cells could help overcome resistance to immunotherapy and improve cellular therapies for pancreatic cancer.

UT-led study finds COVID-19 can awaken hidden viruses throughout the body

Researchers say dormant viruses many people harbor can reactivate during COVID-19 and may be linked to long COVID symptoms.

Panther Life Sciences Appoints Mounir Hanana as Chief Executive Officer

Hanana brings 25 years of experience scaling global technology, consumer, and manufacturing businesses at Amazon and Procter & Gamble. Founder Carlos Bhola continues as Executive Chairman, leading strategy, product vision and corporate development. Hanana joins as Panther begins commercializing its SmartPatch™ platform, starting with cosmetics and medical aesthetics and expanding to therapeutic applications.

Complex-molecule specialist Shilpa CDMO launches at CPHI Milan

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending CluePoints' science-first approach from RBQM into clinical data review. The partner will join CluePoints live at SCDM 2026 to celebrate the launch.

PubHive to Exhibit at WPSC Europe 2026 in Amsterdam

PubHive will exhibit at WPSC Europe 2026, showcasing connected scientific information and smarter safety workflows.

Eppendorf launches new refrigerated Centrifuge 5811 R

The Centrifuge 5811 R succeeds the globally trusted Centrifuge 5810 R It retains the proven performance and versatility of its predecessor while introducing a new design and updated sustainable cooling technology

NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor

Veteran global finance leader Kevin Felix joins NetraMark as Strategic Advisor, bringing institutional investment, capital markets and strategic transaction expertise.

Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil

Biocon has secured a 10-year PDP allocation for pertuzumab in Brazil through a partnership with Bahiafarma and Bionovis, covering around 70% of the country’s public-sector demand. The agreement combines long-term supply with phased local production, supporting affordable cancer treatment access and strengthening Brazil’s domestic biopharmaceutical capabilities.

MIB Agents Now Accepting Letters of Intent for 2027 OutSmarting Osteosarcoma Research Grants

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, families, medical professionals, researchers and industry partners, is accepting letters of intent (LOI) starting on Wednesday, September 9, for its annual OutSmarting Osteosarcoma research grant program.

Integrion Automation Builds on Its Medical Device Capabilities to Support Validated, Traceable Production

Integrion Automation provides validated, traceable automation solutions for medical device manufacturers, helping improve quality, compliance, and flexibility in regulated production environments. Its GAMP 5-based approach, validation services, advanced inspection and assembly technologies, and lifecycle support help manufacturers reduce risk while maintaining audit-ready operations.

Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform

Integrated DNA Technologies (IDT) and Ansa Biotechnologies expand partnership, making it easier for researchers to access longer, more complex DNA.

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Pharmaceutical industry leader brings more than 20 years of global drug development, regulatory strategy and portfolio leadership experience across AbbVie, Merck KGaA, AstraZeneca and Abivax.